Private Advisor Group, LLC Tg Therapeutics, Inc. Transaction History
Private Advisor Group, LLC
- $15.6 Billion
- Q3 2024
A detailed history of Private Advisor Group, LLC transactions in Tg Therapeutics, Inc. stock. As of the latest transaction made, Private Advisor Group, LLC holds 14,407 shares of TGTX stock, worth $415,065. This represents 0.0% of its overall portfolio holdings.
Number of Shares
14,407
Previous 13,865
3.91%
Holding current value
$415,065
Previous $246,000
36.59%
% of portfolio
0.0%
Previous 0.0%
Shares
6 transactions
Others Institutions Holding TGTX
# of Institutions
314Shares Held
93.1MCall Options Held
1.9MPut Options Held
1.45M-
Vanguard Group Inc Valley Forge, PA13.7MShares$394 Million0.0% of portfolio
-
Black Rock Inc. New York, NY11.4MShares$328 Million0.0% of portfolio
-
State Street Corp Boston, MA6.7MShares$193 Million0.01% of portfolio
-
Soleus Capital Management, L.P. Greenwich, CT3.65MShares$105 Million6.57% of portfolio
-
Pictet Asset Management Holding Sa Carouge, V83.24MShares$93.4 Million0.07% of portfolio
About TG THERAPEUTICS, INC.
- Ticker TGTX
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 145,274,000
- Market Cap $4.19B
- Description
- TG Therapeutics, Inc., a commercial stage biopharmaceutical company, focuses on the acquisition, development, and commercialization of novel treatments for B-cell malignancies and autoimmune diseases. Its therapeutic product candidates include Ublituximab, an investigational glycoengineered monoclonal antibody for the treatment of B-cell non-hod...